Back

p63 and PITX1 sustain a pre-invasive malignant keratinocyte population in squamous cell carcinoma precursors

Staeger, R.; Tastanova, A.; Ghosh, A.; Gueguen, P.; Kolm, I.; Ramelyte, E.; Lattmann, E.; Haunerdinger, V.; Karakaya, T.; Slaufova, M.; Di Filippo, M.; Beer, H.-D.; Levesque, M.; Dummer, R.

2026-05-24 cancer biology
10.64898/2026.05.21.725073 bioRxiv
Show abstract

BackgroundCutaneous squamous cell carcinoma (cSCC) is among the most common human cancers, yet the cellular identity and molecular programs of its preinvasive precursor, actinic keratosis (AK), remains poorly defined. MethodsWe applied CITE-seq to patient-matched AK, UV-exposed normal skin, and non-UV-exposed normal skin (n=5 patients, 12 biopsies) and performed spatial whole-transcriptome profiling in an independent cohort (n=4) to map pre-invasive keratinocyte states at single-cell resolution. ResultsWe identify AK-specific keratinocytes (ASK), a discrete population localized to the dysplastic basal epidermis and characterized by UV-associated mutational signatures (SBS7b), high mutational burden, and recurrent copy number alterations including 9p loss and 8q gain. ASK occupies a basal-like undifferentiated state sustained by a {Delta}Np63/PITX1 regulatory module that attenuates Notch/HES1-driven differentiation and activates glycolytic metabolism. Comparison with published cSCC data reveals that ASK share core tumor-propagating gene networks with tumor-specific keratinocytes (TSK), including IGFBP6, IGFBP2, and ITGA6, but lack invasion effectors MMP1, MMP10, and PTHLH. Functional experiments identify IGFBP6 as a pro-proliferative factor in AK-derived keratinocytes. The AK microenvironment shows expansion of inflammatory basal keratinocytes, barrier disruption, and early immunosuppressive T cell remodeling. ConclusionsThese findings define the molecular identity of a pre-invasive malignant keratinocyte population governed by p63/PITX1 and distinguish early oncogenic programs shared with invasive cSCC from later-acquired invasion effectors, identifying candidate targets for prevention or treatment of squamous cell carcinoma.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 11%
16.9%
2
Journal of Investigative Dermatology
49 papers in training set
Top 0.1%
10.9%
3
British Journal of Dermatology
11 papers in training set
Top 0.1%
7.8%
4
JID Innovations
11 papers in training set
Top 0.1%
6.7%
5
Genome Medicine
183 papers in training set
Top 0.5%
6.2%
6
Nature Genetics
286 papers in training set
Top 1%
4.3%
50% of probability mass above
7
Cancer Research
130 papers in training set
Top 0.9%
4.0%
8
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 13%
4.0%
9
eLife
5828 papers in training set
Top 39%
2.6%
10
Cell Reports
1498 papers in training set
Top 15%
2.4%
11
Nature Cell Biology
118 papers in training set
Top 2%
2.1%
12
Science Advances
1243 papers in training set
Top 17%
2.0%
13
JCI Insight
277 papers in training set
Top 4%
1.9%
14
The Journal of Pathology
26 papers in training set
Top 0.4%
1.7%
15
The EMBO Journal
309 papers in training set
Top 3%
1.7%
16
Experimental Dermatology
10 papers in training set
Top 0.2%
1.1%
17
Cell Reports Medicine
153 papers in training set
Top 4%
1.0%
18
Journal of Clinical Investigation
179 papers in training set
Top 6%
0.8%
19
Journal of Experimental Medicine
119 papers in training set
Top 3%
0.8%
20
EMBO Reports
263 papers in training set
Top 7%
0.8%
21
Cell Death & Disease
21 papers in training set
Top 0.4%
0.8%
22
Journal of Translational Medicine
57 papers in training set
Top 2%
0.8%
23
Scientific Reports
3612 papers in training set
Top 79%
0.6%
24
Molecular Oncology
55 papers in training set
Top 2%
0.6%
25
Developmental Cell
196 papers in training set
Top 5%
0.6%